Osteoporosis in primary biliary cirrhosis of the liver

Przeglad Gastroenterologiczny

Volumn 9, Issue 2, 2014, Pages 82-87

  Raszeja Wyszomirska, Joanna ^a   Miazgowski, Tomasz ^b  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Osteoporosis; Primary biliary cirrhosis

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; DENOSUMAB; ETIDRONIC ACID; IMMUNOGLOBULIN; INSULIN; LEPTIN; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; RALOXIFENE; STRONTIUM RANELATE; VITAMIN D;

BONE DENSITY; BONE METABOLISM; BONE REMODELING; CHRONIC LIVER DISEASE; EARLY DIAGNOSIS; FRAGILITY FRACTURE; HEPATIC OSTEODYSTROPHY; HUMAN; LIVER DISEASE; METABOLIC BONE DISEASE; OSTEODYSTROPHY; OSTEOLYSIS; OSTEOMALACIA; OSTEOPOROSIS; PRIMARY BILIARY CIRRHOSIS; PRIMARY OSTEOPOROSIS; REVIEW; RISK FACTOR; VITAMIN SUPPLEMENTATION;

EID: 84900991658     PISSN: 18955770     EISSN: 18974317     Source Type: Journal    
DOI: 10.5114/pg.2014.42502     Document Type: Review

References (38)

1. Mazur W. Pierwotna marskość żółciowa wa̧troby. In: Wielka Interna. Gastroenterologia. Antczak, Myśliwic, Pruszczyk (eds.) [Polish], Medical Tribune Polska 2010; 442-50.
2. Goel V, Kar P. Hepatic osteodystrophy. Trop Gastroenterol 2010; 31: 82-6.
3. Report of a WHO Scientific Group. 2003 Prevention and Management of Osteoporosis. WHO Technical Report Series 921.
4. Parés A, Guanabens N. Osteoporosis in primary biliary cirrhosis: pathogenesis and treatment. Clin Liver Dis 2008; 12: 407-24. (Pubitemid 351635892)
5. Springer JE, Cole DE, Rubin LA, et al. Vitamin D-receptor genotypes as independent genetic predictors of decreased bone mineral density in primary biliary cirrhosis. Gastroenterology 2000; 118: 145-51. (Pubitemid 30020382)
6. Pares A, Guanabens N, Rodes J. Gene polymorphism as predictors of decreased bone mineral density and osteoporosis in primary biliary cirrhosis. Eur J Gastroenterol Hepatol 2005; 17: 311-5. (Pubitemid 40411217)
7. Menon KV, Angulo P, Weston S, et al. Bone disease in primary biliary cirrhosis: independent indicators and rate of progression. J Hepatol 2001; 35: 316-23. (Pubitemid 32844184)
8. Newton J, Francis R, Prince M, et al. Osteoporosis in primary biliary cirrhosis revisited. Gut 2001; 49: 282-7. (Pubitemid 32675124)
9. Solerio E, Isaia G, Innarella R, et al. Osteoporosis: still a typical complication of primary biliary cirrhosis? Dig Liver Dis 2003; 35: 339-46. (Pubitemid 41110861)
10. Guañabens N, Pares A, Ros I, et al. Severity of cholestasis and advanced histological stage but not menopausal status are the major risk factors for osteoporosis in primary biliary cirrhosis. J Hepatol 2005; 42: 573-7. (Pubitemid 40342938)
11. Guichelaar MM, Kendall R, Malinchoc M, Hay JE. Bone mineral density before and after OLT: long-term follow-up and predictive factors. Liver Transpl 2006; 12: 1390-402. (Pubitemid 44405129)
12. Guañabens N, Cerda D, Monegal A, et al. Low bone mass and severity of cholestasis affect fracture risk in patients with primary biliary cirrhosis. Gastroenterology 2010; 138: 2348-56.
13. Guañabens N, Parés A, Mariñoso L, et al. Factors influencing the development of metabolic bone disease in primary biliary cirrhosis. Am J Gastroenterol 1990; 85: 1356-62. (Pubitemid 20360648)
14. Mounach A, Ouzzif Z, Wariaghli G, et al. Primary biliary cirrhosis and osteoporosis: a case-control study. J Bone Miner Metab 2008; 26: 379-84. (Pubitemid 351950694)
15. Solaymani-Dodaran M, Card TR, Aithal GP, et al. Fracture risk in people with primary biliary cirrhosis: a population based cohort study. Gastroenterology 2006; 131: 1752-7. (Pubitemid 44958513)
16. Frith J, Kerr S, Robinson L, et al. Primary biliary cirrhosis is associated with falls and significant fall related injury. QJM 2010; 103: 153-61.
17. Malham M, Jørgensen SP, Ott P, et al. Vitamin D deficiency in cirrhosis relates to liver dysfunction rather than aetiology. World J Gastroenterol 2011; 17: 922-5.
18. Guanabens N, Enjuanes A, Alvarez L, et al. High osteorpotegerin serum levels in primary biliary cirrhosis are associated with disease severity but not with themRNA gene expression in liver tissue. J Bone Miner Metab 2009; 27: 347-54.
19. Szalay F, Hegedus D, Lakatos PL, et al. High serum osteoprotegerin and low RANKL in primary biliary cirrhosis. J Hepatol 2003; 38: 395-400. (Pubitemid 36399239)
20. Stellon AJ, Webb A, Compston J, Williams R. Low bone turnover state in primary biliary cirrhosis. Hepatology 1987; 7: 137-42. (Pubitemid 17019865)
21. Guañabens N, Parés A. Management of osteoporosis in liver disease. Clin Res Hepatol Gastroenterol 2011; 35: 438-45.
22. Guañabens N, Parés A, Alvarez L, et al. Collagen-related markers of bone turnover reflect the severity of liver fibrosis in patients with primary biliary cirrhosis. J Bone Miner Res 1998; 13: 731-8. (Pubitemid 28163024)
23. Cuthbert JA, Pak CY, Zerwekh JE, et al. Bone disease in primary biliary cirrhosis: increased bone resorption and turnover in the absence of osteoporosis or osteomalacia. Hepatology 1984; 4: 1-8. (Pubitemid 14185416)
24. Szalay F, Fohoffer A, Horvath A, et al. Serum leptin, soluble leptin receptor, free leptin index and bone mineral density in patients with primary biliary cirrhosis. Eur J Gastroenterol Hepatol 2005; 17: 923-8. (Pubitemid 41192130)
25. Ben-Ari Z, Schafer Z, Sulkes J, et al. Alterations in serum leptin in chronic liver disease. Dig Dis Sci 2002; 47: 183-9. (Pubitemid 34075037)
26. García-Suárez C, Crespo J, Fernández-Gil PL, et al. Plasma leptin levels in patients with primary biliary cirrhosis and their relationship with degree of fibrosis. Gastroenterol Hepatol 2004; 27: 47-50. (Pubitemid 38279932)
27. Breidert M, Zimmermann TF, Schneider R, et al. Ghrelin/leptin-imbalance in patients with primary biliary cirrhosis. Exp Clin Endocrinol Diabetes 2004; 112: 123-6. (Pubitemid 38445490)
28. Gonnelli S, Caffarelli C, Del Santo K, et al. The relationship of ghrelin and adiponectin with bone mineral density and bone turnover markers in elderly men. Calcif Tissue Int 2008; 83: 55-60.
29. Peng YM, Lei SF, Guo Y, et al. Sex-specific association of the glucocorticoid receptor gene with extreme BMD. J Bone Miner Res 2008; 23: 247-52. (Pubitemid 351160038)
30. Kanazawa I, Yamaguchi T, Yamamoto M, et al. Relationships between serum adiponectin levels versus bone mineral density, bone metabolic markers, and vertebral fractures in type 2 diabetes mellitus. Eur J Endocrinol 2009; 160: 265-73.
31. Kontogianni MD, Dafni UG, Routsias JG, Skopouli FN. Blood leptin and adiponectin as possible mediators of the relation between fat mass and BMD in perimenopausal women. J Bone Miner Res 2004; 19: 546-51. (Pubitemid 41071213)
32. Floreani A, Variola A, Niro G, et al. Plasma adiponectin levels in primary biliary cirrhosis: a novel perspective for link between hypercholesterolemia and protection against atherosclerosis. Am J Gastroenterol 2008; 103: 1959-65.
33. EASL Clinical Practice Guidelines: Management of cholestatic iver diseases. J Hepatol 2009; 51: 237-67.
34. Musialik J, Petelenz M, Gonciarz Z. Effects of alendronate on bone mass in patients with primary biliary cirrhosis and osteoporosis. Preliminary results after 1 year. Scand J Gastroenterol 2005; 40: 873-4. (Pubitemid 40978866)
35. Zein CO, Jorgensen RA, Clarke B, et al. Alendronate improves bone mineral density in primary biliary cirrhosis: a randomized placebo-controlled trial. Hepatology 2005; 42: 762-71. (Pubitemid 41401113)
36. Levy C, Harnois DM, Angulo P, et al. Raloxifen improves bone mass in osteoponeic women with primary biliary cirrhosis: result of pilot study. Liver Int 2005; 25: 117-21. (Pubitemid 40298253)
37. Dresner-Pollak R, Gabet Y, Steimatzky A, et al. Human parathyroid hormone 1-34 prevents bone loss in experimental biliary cirrhosis in rats. Gastroenterology 2008; 134: 259-67. (Pubitemid 350309323)
38. Dempster DW, Lambing CL, Kostenuik PJ, Grauer A. Role of RANK ligand and denosumab, a targeted RANK ligand inhibitor, in bone health and osteoporosis: a review of preclinical and clinical data. Clin Ther 2012; 34: 521-36.